gallbladder disease and semaglutide Does Wegovy (semaglutide) increase the risk of disease? Ozempic Gallbladder Lawsuit Update |

All of this leads to a decrease in blood glucose levels

That said, participants who incorporated regular physical activity, particularly resistance training, tended to preserve more lean muscle mass during rapid weight loss

In recent animal studies, GLP-1 agonists reduced fluid in the central nervous system, thereby lowering intracranial pressure

Common side effects reported in clinical trials include: Gastrointestinal disturbances : cramping, diarrhoea, flatulence, constipation, and abdominal discomfort are the most frequently reported adverse effects, occurring in up to 30% of users in some studies Nausea : particularly when starting treatment or taking higher doses These effects are typically mild to moderate and often improve with continued use or dose reduction Less common but important considerations : Berberine may cause a temporary increase in bilirubin levels, which could be problematic in individuals with liver disease Berberine should not be used during pregnancy or breastfeeding due to potential risks to the foetus or infant (including theoretical risk of kernicterus in infants) Berberine is not recommended for use in children or adolescents Allergic reactions, whilst rare, can occur Significant drug interactions are a major concern: Diabetes medications : Berberine may have additive glucose-lowering effects, particularly with insulin and sulphonylureas, increasing the risk of hypoglycaemia

These additional activity pathways may explain why early studies suggest greater average weight loss with retatrutide

Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes